Status: Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.
Participants needed: 414
Trial details
Age: 19+Biological sex: AllType: InterventionalSponsor: Ulsan University HospitalUpdated: Feb 12, 2026Locations: 5
Eligibility criteria
Adults aged 19 years or older [+4]
Individuals who have difficulty communicating due to cognitive impairment, visua... [+2]